REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VEDOLIZUMAB

被引：0
|
作者：
Glassner, Kerri
Irani, Malcolm
Malaty, Hoda
Abraham, Bincy P.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P052
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [41] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 : S74 - S75
  • [42] Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting
    Kolehmainen, Sara
    Ylisaukko-Oja, Tero
    Jokelainen, Jari
    Koivusalo, Mirkka
    Jokiranta, T. Sakari
    Sipponen, Taina
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 906 - 913
  • [43] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    [J]. INFLAMMATORY BOWEL DISEASES, 2024, 30 : S73 - S74
  • [44] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Anjur, Kavya
    Neiman, Nicole
    Kotzen, Alison
    Pond, Stephen
    Goyal, Alka
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S826 - S826
  • [45] OUTCOMES OF DOSE ESCALATION AND DRUG LEVEL MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Scoville, Elizabeth A.
    Izmaylov, Michelle L.
    Bennett, Audrey
    Evers, Lauren
    Annis, Kim
    Garrett, Ailish
    Duley, Caroline
    Adams, Dawn W.
    Dalal, Robin L.
    Beaulieu, Dawn
    Schwartz, David A.
    Horst, Sara N.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S829 - S830
  • [46] RISK OF INFECTIOUS COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH VEDOLIZUMAB: A REAL LIFE EXPERIENCE
    Apolito, P.
    Innocenti, T.
    Roselli, J.
    Parisio, L.
    Macri, G.
    Bagnoli, S.
    Rogai, F.
    Galli, A.
    Milla, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 : S123 - S123
  • [47] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [48] Therapeutic drug monitoring in inflammatory bowel disease treatments
    Wang, Meng-Yao
    Zhao, Jing-Wen
    Zheng, Chang-Qing
    Sang, Li-Xuan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (15) : 1604 - 1607
  • [49] Ustekinumab Therapeutic Drug Monitoring in Inflammatory Bowel Disease
    Saleh, Adam A.
    Stading, Rachel
    Miroballi, Natalia
    Glassner, Kerri
    Abraham, Bincy
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S636 - S637
  • [50] REAL WORLD OUTCOMES OF VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE POST LIVER TRANSPLANTATION
    Peverelle, Matthew
    Mills, Christopher D.
    Testro, Adam
    De Cruz, Peter
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S845 - S845
12345